Nektar Therapeutics (NAS:NKTR) Stock News, Headlines & Updates
Nektar Therapeutics Stock News from GuruFocus
- 1
Aug 08, 2024
Nektar Therapeutics Q2 2024 Earnings: Revenue Surpasses Estimates at $23.5M, EPS Misses at -$0.25
GuruFocus Research • 4:04pm
Nektar Therapeutics Reports Second Quarter 2024 Financial Results
PRNewswire • 4:01pm
Aug 01, 2024
Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets
PRNewswire • 6:00pm
Jun 12, 2024
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
PRNewswire • 9:00am
May 30, 2024
Nektar Management to Present at Upcoming Investor Conferences
PRNewswire • 6:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news